The Indianapolis-based education reform group The Mind Trust will announce June 25 that it is awarding $1 million apiece to Indianapolis-based Christel House Academy and Boston-based Phalen Leadership Academies to launch new charter schools in Indianapolis.
Six months after the Mind Trust released its plan to reform Indianapolis Public Schools, researchers at Indiana University now say the plan rests on experiments in other cities that led to greater inequity among students and did not produce dramatic academic gains.
Roche Diagnostics Corp. plans to spend $300 million on an expansion of its Indianapolis headquarters, creating 100 jobs by 2017, the company said Wednesday.
The U.S. Supreme Court did not hand down a ruling in the health care reform case Monday morning. The nine justices meet again Thursday, but most observers expect the decision to come June 25 or June 28.
The skies got a little brighter for the orthopedic industry on Friday after Warsaw-based Biomet Inc. reported strong quarterly sales growth of 3.4 percent. That news sparked a small surge in the stock prices of two other Warsaw-based orthopedics companies.
Sam Odle, one of Indianapolis’ most prominent black business leaders, will be replaced on an interim basis by Jim Terwilliger while the hospital system conducts a national search for his successor.
While mergers and acquisitions have been rampant in central Indiana’s benefits-broker industry the past five years, a handful of brokers has grown the old-fashioned way—by adding clients.
Eli Lilly and Co. has invested $20 million in Chinese pharmaceutical company Novast Labs in an effort to build up a portfolio of branded generic medicines in the fast-growing Asian market.
Eli Lilly and Co. announced positive results for an experiemental insulin at the annual American Diabetes Association conference in Philadelphia, but was still upstaged by Denmark-based Novo Nordisk A/S.
Even though employers expect the U.S. Supreme Court to strike down at least some of the 2010 health reform law later this month, few are actually doing any contingency planning.
The Warsaw area is well-known as the home of gigantic orthopedic implant companies and their suppliers. But now a handful of startups have been able to raise nearly $25 million in equity investments despite the recession—putting a bit more fuel into a fairly stagnant entrepreneurial sector.
The question at the heart of this year’s debate over the future of Indianapolis Public Schools is whether the district should be placed in the hands of Indianapolis’ mayor. But when mayors take control of bad schools, test scores usually rise but challenges don’t go away.
The future of health insurance is lower profit margins and greater consumer control. WellPoint Inc. just bet $900 million on it.
It took the identification of 19 different genes for researchers at the Indiana University School of Medicine to develop a test for a rare form of cancer. But their gene-hunting has paid off, as a Texas-based company announced Monday the test is available for doctors to use.
Three “blended learning” educational organizations have been approved to open 19 charter schools here that combine online technology and face-to-face instruction. The strategy allows schools to save money by employing fewer teachers, yet also can produce impressive student results.
Bioanalytical Systems Inc.’s new chief financial officer recently received praise from one of the company’s institutional investors for laying out an aggressive cost-cutting plan—but not before the rest of the firm’s leaders got a tongue-lashing for past performance. “We’re glad to see somebody aggressively attacking the cost basis, because the costs have been out of […]
Newly available data from private health insurance plans show that price hikes by hospitals, doctors and drug companies have kept employer spending rising recently even as their employees and dependents have moderated their consumption of health care services.
Bioanalytical Systems Inc.’s new CFO won praise this month for laying out an aggressive cost-cutting plan—but not before the rest of the company’s leaders got a tongue lashing for their past performance.
By the end of 2012, Medical Informatics Engineering anticipates that its six-person Indianapolis workforce will have doubled to 12, then to as many as 25 over the following year or so.
Most analysts agree with Eli Lilly and Co.’s prediction that, after tough years from 2012 to 2014, the drugmaker will start growing sales and profits again. But in a new report, BMO Capital Markets predicts Lilly will get stuck at a reduced level of revenue and profit in 2014 and stay there for years. “We […]
